Ketamin Abcur (Ketamine)

Ketamine acts as a non‑competitive antagonist at the NMDA receptor, blocking the phencyclidine site and reducing excitatory glutamate signaling. This leads to dissociation, analgesia, and amnesia. It also stimulates opioid receptors and triggers catecholamine release, which helps preserve cardiovascular stability during anesthesia.

The dose of Ketamin Abcur is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and the intended use (e.g., induction, sedation, or analgesia). Specific dosing regimens are outlined in local prescribing information and should not be altered without medical guidance.

Safety data for ketamine in pregnancy and lactation are limited. The drug is generally classified as contraindicated or used only when the potential benefit justifies the potential risk to the fetus or infant. Clinicians should evaluate the risk‑benefit profile before prescribing to pregnant or nursing patients.

To request Ketamin Abcur, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Ketamine differs from many inhalational or intravenous anesthetics by providing both analgesia and dissociative anesthesia while preserving airway reflexes and stimulating cardiovascular output. Unlike propofol or volatile agents, it does not cause significant respiratory depression, making it useful in hemodynamically unstable patients, though it may produce emergence phenomena not seen with other agents.

Ketamin Abcur should be stored at ambient temperature, preferably below 25 °C. Keep the vials in their original packaging, protect them from moisture and direct light, and ensure the container is tightly sealed to maintain sterility until use.

Ketamin Abcur is supplied as a sterile injectable solution for intramuscular or intravenous administration. The route, rate of injection, and total dose are determined by the treating physician based on the clinical indication and patient characteristics.

The most serious adverse events include respiratory depression, severe hypertension or cardiac arrhythmias, emergence delirium, and urinary tract toxicity with prolonged use. Prompt monitoring of airway, breathing, circulation, and mental status is essential to detect and manage these complications early.

Ketamin Abcur is contraindicated in patients with known hypersensitivity to ketamine, uncontrolled severe hypertension, or severe psychotic disorders. Caution is advised in individuals with cardiovascular disease, elevated intracranial pressure, or a history of substance abuse. The drug should be avoided in these populations unless the benefits clearly outweigh the risks.